Design
Review
Authors
Loading...
Endothelin-1 pathways remain investigational in atherosclerosis; review leaves open clinical efficacy pending randomized outcome trials.
Key points are not available for this paper at this time.
Little et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: